NewsAI-assisted

Miror Therapeutics Signs Awareness Partnership with BESCOM and Soham Foundation for Menopause Education

Miror Therapeutics partners with BESCOM and Soham Foundation to deliver menopause and HRT awareness at BESCOM's Bengaluru headquarters.

Vaibhavi M.
By Vaibhavi M.
Subject Matter Expert (B.Pharm) · Pharma Now
May 11, 2026Updated May 22, 2026 · 2 min read
Share
Miror Therapeutics Signs Awareness Partnership with BESCOM and Soham Foundation for Menopause Education
AI-assisted reporting
Reviewed by Vaibhavi M., Subject Matter Expert (B.Pharm) · Pharma Now
40/ 100
Trust score
Needs review

Miror Therapeutics has moved menopause education into the occupational health space, partnering with BESCOM and the Soham Foundation to deliver structured awareness programming on perimenopause, menopause, and hormone replacement therapy to women employees at BESCOM's Bengaluru headquarters.

The initiative targets a gap that workplace health programmes have historically underserved: the clinical and quality-of-life dimensions of the menopausal transition, including perimenopause recognition and HRT options. By situating the programme within a large public-sector utility, Miror Therapeutics is testing a channel that sits outside conventional patient outreach and closer to occupational medicine frameworks.

For medical affairs and health economics teams tracking real-world engagement models, the BESCOM collaboration signals a shift toward employer-mediated health literacy as a route to earlier clinical intervention. The Soham Foundation's involvement adds a structured non-profit layer, which may inform how similar programmes are designed for regulatory and ethical review in corporate health contexts.

The scope of the programme beyond the Bengaluru headquarters event has not been disclosed, leaving open questions about scalability, outcome measurement, and whether the initiative will generate data relevant to therapeutic uptake or prescribing patterns.

Source: Media4Growth via Indian Pharma Post, 10 May 2026.

TopicsNews
Vaibhavi M.
Written by
Vaibhavi M.
Subject Matter Expert (B.Pharm) · Pharma Now

Reporting on the science, business and regulation shaping the pharmaceutical industry.

Discussion

Loading discussion…

More from Pharma News

All stories →